Ketamine/esketamine pharmacotherapy for treatment of anxiety disorders and anxiety symptoms in depression: Systematic review
There are indications that es/ketamine pharmacotherapy may reduce pathological anxiety, although relapse may follow its termination. More studies are needed to confirm these preliminary findings.
Authors
- Vasilios G. Masdrakis (ORCID: https://orcid.org/0000-0003-0197-9583)
- David S. Baldwin (ORCID: https://orcid.org/0000-0003-3343-0907)
- Zoe Tebbs (ORCID: https://orcid.org/0009-0005-6140-752X)
- Vasilios Natsis
Institutions
- Eginition Hospital (GR)
- University of Southampton (GB)
Publication Details
- Journal
- Journal of Psychopharmacology
- Published
- 2025-12-04
- DOI
- https://doi.org/10.1177/02698811251389583
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 0.00